Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-109.07%Return on Equity
VS
Market
Sector
Industry
History
$ 3.48Close
$ 1.43 - $ 5.13 52-Week Range
Ticker Information
Ticker
TCRTCompany Name
ALAUNOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALAUNOS THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TCRT - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 3.66M | $ -3.99M | -109.07% |
| 3/31/2025 | $ 1.06M | $ -4.07M | -384.78% |
| 12/31/2024 | $ 2.06M | $ -4.68M | -226.81% |
| 9/30/2024 | $ 2.72M | $ -11.78M | -432.49% |
| 6/30/2024 | $ 3.77M | $ -19.13M | -507.29% |
| 3/31/2024 | $ 4.8M | $ -26.77M | -558.14% |
| 12/31/2023 | $ 6.31M | $ -35.14M | -557.16% |
| 9/30/2023 | $ 13.9M | $ -36.46M | -262.27% |
| 6/30/2023 | $ 21.65M | $ -36.83M | -170.12% |
| 3/31/2023 | $ 29.51M | $ -37.99M | -128.74% |
Key Performance Insights, Last 5 Years
- ALAUNOS THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -50.34%.
- Over the past 5 years, ALAUNOS THERAPEUTICS INC's average ROE has been -219.53%.
- The median ROE for ALAUNOS THERAPEUTICS INC during this period was -135.33%
- ALAUNOS THERAPEUTICS INC reached its highest ROE over the past 5 years at -50.34%.
- The lowest ROE recorded by ALAUNOS THERAPEUTICS INC in the same timeframe -558.14%
ALAUNOS THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ALAUNOS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -72.95M ] / Equity [ $ 144.92M ]
(=) ROE [ -50.34% ] TCRT - Return on Equity, Last 5 years
-558.14%
Minimum
Mar 31, 2024
-50.34%
Maximum
Sep 30, 2020
-219.53%
Average
-135.33%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |